ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 161 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,839,723 | +107.5% | 142,900 | +175.3% | 0.01% | +100.0% |
Q2 2023 | $1,850,754 | +127.7% | 51,900 | +62.2% | 0.01% | +150.0% |
Q1 2023 | $812,800 | -35.8% | 32,000 | +57.6% | 0.00% | -33.3% |
Q3 2021 | $1,267,000 | -71.6% | 20,300 | -62.3% | 0.00% | -75.0% |
Q2 2021 | $4,456,000 | -32.7% | 53,800 | -46.1% | 0.01% | -33.3% |
Q1 2021 | $6,618,000 | +59.1% | 99,800 | +84.1% | 0.02% | +63.6% |
Q4 2020 | $4,159,000 | -50.5% | 54,200 | -72.2% | 0.01% | -54.2% |
Q3 2020 | $8,410,000 | -70.6% | 195,300 | -70.5% | 0.02% | -71.4% |
Q2 2020 | $28,639,000 | +59.1% | 663,100 | +6.0% | 0.08% | +21.7% |
Q1 2020 | $17,996,000 | +84.0% | 625,500 | +305.6% | 0.07% | +200.0% |
Q4 2019 | $9,781,000 | +233.7% | 154,200 | +48.3% | 0.02% | +228.6% |
Q3 2019 | $2,931,000 | -54.4% | 104,000 | -57.1% | 0.01% | -56.2% |
Q2 2019 | $6,424,000 | +368.6% | 242,400 | +224.5% | 0.02% | +433.3% |
Q1 2019 | $1,371,000 | +258.0% | 74,700 | +273.5% | 0.00% | +200.0% |
Q3 2018 | $383,000 | – | 20,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |